Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 31;21(1):303.
doi: 10.1186/s12906-021-03490-0.

Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats

Affiliations

Oral administration of tartrazine (E102) accelerates the incidence and the development of 7,12-dimethylbenz(a) anthracene (DMBA)-induced breast cancer in rats

Stéphane Zingue et al. BMC Complement Med Ther. .

Abstract

Background: Despite the considerable advances made in the treatment of cancer, it remains a global threat. Tartrazine (E102) is a synthetic dye widely used in food industries; it has recently been shown to induce oxidative stress (a well known risk factor of cancer) in rat tissues. The present work therefore aimed to assess the impact of a regular consumption of tartrazine on the incidence of breast cancer in rats.

Methods: Forty (40) Wistar rats aged 55 to 60 days were randomly assigned into 5 groups (n = 8) including two groups serving as normal controls and receiving distilled water (NOR) or tartrazine (NOR + TARZ). The three remaining groups were exposed to the carcinogen DMBA (50 mg/kg) and treated for 20 weeks with either distilled water (DMBA), tartrazine 50 mg/kg (DMBA + TARZ) or a natural dye (DMBA + COL). The parameters evaluated were the incidence, morphology and some biomarkers (CA 15-3, estradiol and α-fetoprotein) of breast cancer. The oxidative status and histomorphology of the tumors were also assessed.

Results: A regular intake of tartrazine led to an early incidence of tumors (100% in rats that received TARZ only vs 80% in rats that received DMBA only), with significantly larger tumors (p < 0.001) (mass = 3500 mg/kg and volume = 4 cm3). The invasive breast carcinoma observed on the histological sections of the animals of the DMBA + TARZ group was more developed than those of the DMBA group. The increase in serum α-fetoprotein (p < 0.05) and CA 15-3 (p < 0.01) levels corroborate the changes observed in tumors. The presence of oxidative activity in animals of the DMBA + TARZ group was confirmed by a significant decrease (p < 0.001) in the activity of antioxidant enzymes (SOD and catalase) as well as the level of GSH and increase in the level of MDA compared to the rats of the DMBA and NOR groups.

Conclusion: Tartrazine therefore appears to be a promoter of DMBA-induced breast tumorigenesis in rats through its oxidative potential. This work encourages further studies on the mechanisms of action of tartrazine (E102) and its limits of use.

Keywords: 7,12 dimethylbenz(a) anthracene, alpha-fetoprotein; Breast cancer; CA 15–3; Oxidant; Tartrazine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Effects of tartrazine on the incidence of tumors. DMBA = Animals serving as negative control receiving distilled water; DMBA + TARZ = Animals receiving tartrazine at a dose of 50 mg/kg; DMBA + COL = Animals receiving a natural dye at a dose of 50 mg/kg. Dots represent means ± SEM (n = 8). All animals were exposed to a single dose of DMBA (50 mg/kg)
Fig. 2
Fig. 2
Effects of tartrazine on tumor morphology (A), tumor volume (B) and tumor weight (C). NOR = Animals serving as a normal control receiving distilled water; DMBA = Animals serving as negative control receiving distilled water; DMBA + TARZ = Animals receiving tartrazine at a dose of 50 mg/kg; DMBA + COL = Animals receiving a natural dye at a dose of 50 mg/kg. Dots represent means ± SEM (n = 8). All animals were exposed to a single dose of DMBA (50 mg/kg). ### p < 0.001 compared to the NOR group; *** p < 0.001 compared to the DMBA group
Fig. 3
Fig. 3
Effects of tartrazine on serum α-fetoprotein (A), CA 15–3 (B) and estradiol (C) levels. NOR = Animals serving as a normal control receiving distilled water; DMBA = Animals serving as negative control receiving distilled water; DMBA + TARZ = Animals receiving tartrazine at a dose of 50 mg/kg; DMBA + COL = Animals receiving a natural dye at a dose of 50 mg/kg. The points represent the means ± ESM (n = 8). All animals were exposed to a single dose of DMBA (50 mg/kg). #p < 0.05 compared to the NOR group; * p < 0.05, ** p < 0.01 *** p < 0.001 compared to the DMBA group
Fig. 4
Fig. 4
Photomicrographs (H&E × 25 and H&E × 100) of cross section of mammary glands and tumors after exposure to different substances. NOR = Animals serving as a normal control receiving distilled water; DMBA = Animals serving as negative control receiving distilled water; DMBA + TARZ = Animals receiving tartrazine at a dose of 50 mg/kg; DMBA + COL = Animals receiving a natural dye at a dose of 50 mg/kg. Ca = carcinoma; At = adipose tissue; Se = Eosinophilic secretion, L = lobule; HLU = Hypertrophied lobular unit

Similar articles

Cited by

References

    1. Sarkar B, Ullah A, Islam S, Hossain S. Anticancer potential of medicinal plants from Bangladesh and their effective compounds against cancer. J PharmacognPhytochem. 2019;8:827–833.
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer JClin. 2018;68:394–424. - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, (2018) CA Cancer J Clin. 2018;68:7–30. - PubMed
    1. Zingue S, Atenguena EO, Zingue LL, Tueche AB, Njamen D, Nkoum AB, Ndom P. Epidemiological and clinical profile, and survival of patients followed for breast cancer between 2010 and 2015 at the Yaounde General Hospital, Cameroon. Pan Afr Med J. 2021;39:182. doi: 10.11604/pamj.2021.39.182.26866. - DOI - PMC - PubMed
    1. Lalloo E, Evans DG. Familiar breast cancer. Clin Genet. 2012;82:105–114. - PubMed

MeSH terms